Acute systemic inflammation exacerbates neuroinflammation in Alzheimer's disease: IL‐1β drives amplified responses in primed astrocytes and neuronal network dysfunction
0301 basic medicine
570
Amyloid
Inflammasomes
Interleukin-1beta
IL-1β disrupted hippocampal gamma rhythm
Vulnerability
Alzheimer’s disease (AD)
Mice, Transgenic
Network dysfunction
Hippocampus
Mice
03 medical and health sciences
Neuroinflammation
Memory
Alzheimer Disease
616
Animals
Humans
Gamma
Cytokine
APP/PS1
Inflammation
Neurons
trigger delirium
Delirium
Brain
3. Good health
IL-1β
Chemokine
Priming
Astrocytes
Cytokines
Dementia
Microglia
Primed
Astrocyte
CCL2
DOI:
10.1002/alz.12341
Publication Date:
2021-06-04T09:33:27Z
AUTHORS (16)
ABSTRACT
Neuroinflammation contributes to Alzheimer's disease (AD) progression. Secondary inflammatory insults trigger delirium and can accelerate cognitive decline. Individual cellular contributors this vulnerability require elucidation. Using APP/PS1 mice AD brain, we studied secondary investigate hypersensitive responses in microglia, astrocytes, neurons, human brain tissue. The NLRP3 inflammasome was assembled surrounding amyloid beta, microglia were primed, facilitating exaggerated interleukin-1β (IL-1β) subsequent LPS stimulation. Astrocytes primed produce chemokine intrahippocampal IL-1β. Systemic triggered microglial IL-1β, astrocytic chemokines, IL-6, acute dysfunction, whereas IL-1β disrupted hippocampal gamma rhythm, all selectively mice. Brains from patients with infection showed elevated IL-6 levels. Therefore, leaves the vulnerable inflammation at microglial, astrocytic, neuronal, levels, amplifies neuroinflammatory cytokine synthesis humans. Exacerbation of neuroinflammation deleterious outcomes like accelerated progression merits careful investigation
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (106)
CITATIONS (169)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....